Key terms

About KRMD

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest KRMD news

May 02 9:01am ET Wall Street Analysts Are Bullish on Top Healthcare Picks May 02 8:45am ET Craig-Hallum Sticks to Their Buy Rating for REPRO-MED Systems (KRMD) May 02 1:45am ET REPRO-MED Systems: Strong Start to Fiscal Year 2024 with Strategic Growth and Consistent Margins May 01 4:09pm ET Koru Medical reports Q1 EPS (4c), consensus (4c) Mar 14 7:20am ET Analysts’ Top Healthcare Picks: REPRO-MED Systems (KRMD), Catalyst Pharma (CPRX) Mar 14 7:18am ET Buy Rating Affirmed for REPRO-MED Systems on Strong Growth Prospects and Innovative Expansion Mar 14 1:55am ET Buy Rating Justified: REPRO-MED Systems’ Strong Growth Prospects and Solid Financial Performance Mar 13 4:07pm ET Koru Medical sees FY24 revenue $31.2M-$32.2M, consensus $32.26M Mar 13 4:06pm ET Koru Medical reports Q4 adjusted EPS (2c), consensus (4c) Mar 12 9:02am ET Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD) Mar 11 4:06pm ET Koru Medical announces feasibility study for rare disease therapy Mar 11 8:40am ET Analysts Offer Insights on Healthcare Companies: Clene (CLNN), REPRO-MED Systems (KRMD) and Bioventus (BVS) Mar 06 9:45am ET Craig-Hallum Keeps Their Buy Rating on REPRO-MED Systems (KRMD) Mar 06 8:56am ET Lake Street Sticks to Their Buy Rating for REPRO-MED Systems (KRMD) Mar 06 7:11am ET Koru Medical executes Phase 3 SCIg clinical supply deal with pharma partner Mar 06 12:15am ET Buy Rating Affirmed for KORU Medical Systems Amidst Growth and Market Expansion Prospects

No recent press releases are available for KRMD

KRMD Financials

1-year income & revenue

Key terms

KRMD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

KRMD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms